Thank you for visiting the Astellas Pharma Inc. Website.
You will enter external sites beyond here.
(This link opens in a new window)
Basic Policy on Shareholder Return:
The Company works aggressively towards increasing enterprise value on a continual basis and, as a consequence, improves its return to shareholders. While putting priority on business investment to assure future growth, the Company strives to increase dividend payments stably and continuously based on its medium- to long-term profit growth on a consolidated basis. Further, the Company flexibly acquires its own shares whenever necessary to increase capital efficiency and shareholder return.
Dividend
Record Date for Dividend:
Year-end dividend - March 31 Interim dividend - September 30
Historical Data of Dividend and DOE
| IFRS | ||||
|---|---|---|---|---|
| Dividend (Unit: Yen / share) | DOE (%) | |||
| Interim dividend |
Year-end dividend |
Annual dividend |
Annual DOE |
|
| FY2020 | 21 (planned) |
21 (planned) |
42 (planned) |
|
| FY2019 | 20 | 20 | 40 | 5.9 |
| FY2018 | 19 | 19 | 38 | 5.8 |
| FY2017 | 18 | 18 | 36 | 5.7 |
| FY2016 | 17 | 17 | 34 | 5.6 |
Notes: The Astellas Group has adopted the International Financial Reporting Standards ("IFRS"), effective from the fiscal year ended March 31, 2014.
Notes: In accordance with the Company's Articles of Incorporation, if cash dividends are not claimed for three (3) full years from the day of commencement of payment, the Company shall be relieved of the obligation to make such payment.
Share Buyback and Cancellation of Treasury Stock
| Acquisition period |
Shares acquired | Total acquisition cost (thousand yen) |
|
|---|---|---|---|
| Nov. 1 2019 - Jan. 31 2020 |
27,036,100 | 49,999,815 | |
| Feb. 1 - Mar. 20 2019 |
35,368,900 | 59,999,863 | |
| Jun. 1 - Sep. 20 2018 |
55,475,800 | 99,999,960 | |
| Feb. 1 - Mar. 23 2018 |
39,577,500 | 59,999,993 | |
| Jul. 31 - Oct. 31 2017 |
49,298,000 | 69,999,960 | |
| Feb. 1 - Mar. 22 2017 |
30,000,000 | 45,525,514 | |
| Oct. 31 - Dec. 22 2016 |
30,000,000 | 45,895,995 | |
| Feb. 1 - Mar. 1 2016 |
17,000,000 | 27,455,199 | |
| Nov. 2 - Dec. 1 2015 |
16,000,000 | 27,979,393 | |
| Aug. 3 - Aug. 26 2015 |
15,000,000 | 28,211,012 | |
| May. 28 - Jul. 10 2015 |
20,000,000 | 35,619,462 | |
| Feb. 3 - Mar. 13 2015 |
15,000,000 | 28,214,129 | |
| Nov. 5 - Dec. 12 2013 |
5,037,500 | 29,999,950 | |
| Feb. 4 - Mar. 18 2013 |
6,000,000 | 29,847,367 | |
| Nov. 5 - Dec. 10 2012 |
4,800,000 | 19,524,140 | |
| Nov. 9 - Dec. 11 2009 |
8,200,000 | 26,961,398 | |
| Nov. 7 - Dec. 12 2008 |
9,000,000 | 35,068,665 | |
| Aug. 4 - Aug. 21 2008 |
10,000,000 | 48,351,108 | |
| May. 15 - Jun. 20 2008 |
9,085,500 | 39,999,735 | |
| Dec. 3 2007 - Jan. 18 2008 |
8,000,000 | 38,684,248 | |
| Aug. 29 - Sep. 10 2007 |
8,300,000 | 43,088,442 | |
| Oct. 5 - Dec. 19 2006 |
29,046,300 | 149,999,577 | |
| Aug. 2 - Sep. 20 2006 |
14,985,400 | 69,911,303 | |
| Nov. 8 - Dec. 8 2005 |
5,979,300 | 26,999,916 | |
| Aug. 3 - Aug. 31 2005 |
5,000,000 | 19,172,363 |
| Date of cancellation | Shares cancelled | Shares cancelled as a percentage of all outstanding shares issued prior to the cancellation |
|
|---|---|---|---|
| Feb 14, 2020 | 27,036,100 | 1.45% | |
| May 31, 2019 | 91,000,000 | 4.60% | |
| May 31, 2018 | 89,000,000 | 4.30% | |
| May 31, 2017 | 85,000,000 | 3.95% | |
| June 20, 2016 | 68,000,000 | 3.06% | |
| May 29, 2015 | 38,000,000 | 1.68% | |
| May 30, 2014 | 25,000,000 | 1.09% | |
| May 31, 2013 | 11,000,000 | 2.40% | |
| May 31, 2010 | 8,000,000 | 1.68% | |
| June 23, 2009 | 28,000,000 | 5.56% | |
| June 24, 2008 | 15,000,000 | 2.89% | |
| June 26, 2007 | 45,000,000 | 7.98% | |
| May 31, 2006 | 10,000,000 | 1.74% |
